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ABSTRACT: Glycerol-3-phosphate  acyltransferases  (GPAT)  catalyze  the  first  and  rate-limiting
step  in  the de novo glycerolipid synthesis. The GPAT2 isoform differs from the other
isoforms because its expression  is  restricted  to  male  germ  cells  and  cancer  cells.    It  has
been  recently  reported  that GPAT2  expression  in  mouse  testis  fluctuates  during  sexual  matur-
ation  and  that  it  is  regulated  by epigenetic mechanisms in combination with vitamin A derivat-
ives.   Despite progress made in this field, information about GPAT2 role in the developing male
germ cells remains unclear.  The aim of this  study  was  to  confirm  the  hypothesis  that  GPAT2
is  required  for  the  normal  physiology  of testes  and  male  germ  cell  maturation.    The  gene
was  silenced  in  vivo  by  inoculating  lentiviral particles  carrying  the  sequence  of  a  short-hair-
pin  RNA  targeting Gpat2  mRNA  into  mouse  testis. Histological  and  gene  expression  analysis
showed  impaired  spermatogenesis  and  arrest  at  the pachytene   stage.      Defects   in   repro-
ductive   fitness   were   also   observed,   and   the   analysis   of apoptosis-related  gene  expression
demonstrated  the  activation  of  apoptosis  in Gpat2-silenced germ cells.  These findings indic-
ate that GPAT2 protein is necessary for the normal development of male  gonocytes,  and  that
its  absence  triggers  apoptotic  mechanisms,  thereby  decreasing  the number of dividing germ
cells.
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ABBREVIATIONS 
GPAT: Glycerol-3-phosphate acyltransferase 
KD: knock-down 
KO: knock-out 
shRNA: short-hairpin RNA 
CT: cancer-testis  
TAG: triacylglycerol 
WT: wild type   
RA: retinoic acid 
FBS: fetal-bovine serum 
Dpp: Days post-partum 
FC: fold-change 
 
FULL TEXT OF THE PAPER 
Introduction 
Glycerol-3-phosphate acyltransferases (GPAT) catalyze the first and rate-limiting step in de novo 
glycerolipid synthesis: the acylation of glycerol-3-phosphate with an acyl-CoA.  Four isoforms, 
SUMMARY STATEMENT
The  product  of  the Gpat2  gene  is  highly  expressed  in  testis.    In  vivo Gpat2  silencing  in  testis
arrested  spermatogenesis  before  the  pachytene  stage,  increasing  the  expression  of  apoptosis-
related genes.
SHORT TITLE
GPAT2 is required for spermatogenesis
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product of different genes, have been identified in mammalian cells, the mitochondrial GPAT1 and 
GPAT2 and the endoplasmic reticulum GPAT3 and GPAT4 [1].  GPAT2 was first detected in liver 
mitochondria from Gpat1 -/- mice with an antibody raised against GPAT1 [2], and the mouse gene 
was then cloned based on sequence homology to Gpat1 [3].  Although it is highly similar to GPAT1 
in its subcellular location, structure and sequence, GPAT2 has several characteristics that 
distinguish it from the other isoforms.  GPAT1, GPAT3 and GPAT4 are expressed in lipogenic 
tissues and their activities are primarily associated with triacylglycerol (TAG) and phospholipid 
synthesis, using saturated and monounsaturated acyl-CoA as their major substrates.  In contrast, 
GPAT2 is highly expressed in testis [3], and the overexpressed protein specifically esterifies 
arachidonoyl-CoA to both glycerol-3-phosphate and to 1-acylglycerol-3-phosphate [4].  Moreover, 
GPAT2 does not functionally substitute GPAT1, since compared to WT mice, Gpat1 -/- mice have 
reduced weight, lower content of liver TAG, and altered glycerolipid fatty acid composition [5].  In 
addition, Gpat2 mRNA expression is neither regulated by the nutritional status of the animals [3] 
nor induced when 3T3-L1 fibroblasts differentiate into adipocytes [6].  Human GPAT2 is also 
ectopically expressed in some cancers and promotes a malignant phenotype [7].  These tissue-
expression features together with the influence of GPAT2 on tumor progression led to the 
classification of this gene as a member of the Cancer Testis (CT) family, a group of genes expressed 
almost exclusively in normal testis and some tumors, which is important at specific stages of 
spermatogenesis [7,8].  CT genes are pathologically overexpressed in cancers of different origins 
and generally contribute to tumorigenesis and metastasis, which make them promising targets for 
directed immunotherapy [9].  In short, the testis expresses many of the oncogenes that are usually 
restricted to cancer cells [8].   
Spermatogenesis is a complex developmental process during which spermatogonial stem cells 
divide, differentiate, and ultimately give rise to haploid spermatozoa.  These processes occur 
within the seminiferous tubules which contain germ cells and Sertoli cells that create a 
microenvironment that sustains the generation of spermatozoa.  This process can be divided into 
three phases: mitotic, meiotic, and spermiogenesis during which haploid round spermatids 
elongate and are released into the lumen of the seminiferous tubules as spermatozoa [10].  To 
achieve precise homeostasis in the adult, germ cell renewal, proliferation, export, and apoptosis 
must be finely balanced, a process that appears to occur at the cost of substantial germ cell 
wastage; as much as 75% of potential spermatozoa degenerate in the testes of adult mammals.  
Because Sertoli cells can only support a limited number of developing germ cells, the number of 
Sertoli cells present in adults determines the daily gamete production and apoptosis [11,12].  
Additionally, spermatogenesis is strictly regulated and, in general terms, depends on the 
synchronized action of the hypothalamic-pituitary-gonadal axis and on epigenetics and small non-
coding RNAs action [13,14,15].  
Gpat2 expression in mouse testis is maximal at the pachytene stage, and its transcription is 
regulated by epigenetic mechanisms in combination with retinoic acid (RA) [6].  In addition, GPAT2 
is required for piRNA biogenesis (16).  PiRNAs are highly expressed in male germ cells and have 
broad functions in germline development, including transposon silencing and epigenetic 
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regulation [16,17,18].  Their name refers to Piwi-interacting RNA due to their relationship with 
members of the PIWI protein subfamily, such as the murine homologs MIWI, MILI and MIWI2.  
Based on their stage-specific expression, mammalian piRNAs can be classified into three groups: 
fetal, post-natal pre-pachytene, and pachytene piRNAs [19].  The first two groups are enriched in 
transposon sequences, coexpressed with MIWI2 and/or MILI in early stages of spermatogenesis, 
are primarily involved in de novo DNA methylation in fetal and perinatal male germ cells, and 
control retrotransposon expression [20].  Pachytene piRNAs, which are massively induced 
primarily from nontransposon intergenic regions in pachytene spermatocytes and post meiotic 
spermatids, generally do not target transposons, and their precise function is unknown [20].  
These piRNAs are produced by primary processing, and GPAT2 is required for primary piRNA 
biogenesis [16].  Pachytene piRNAs are responsible for eliminating bulk mRNAs in spermatids 
during spermiogenesis, but are not always directly involved in the control of retrotransposon 
expression [20,21].  The mechanism by which GPAT2 promotes piRNA production remains 
unknown, but because promotion occurs in the absence of the acyltransferase motif H(X4)D, 
regulation of piRNA production by GPAT2 is unlikely to require acyltransferase enzymatic activity 
[16].  The importance of PIWI proteins for the normal progression of spermatogenesis has been 
extensively documented and in mouse knock-out (KO) models, spermatogenesis stops at different 
stages [22,23,24,25]. 
Because the role of GPAT2 in developing male germ cells remains unclear, we investigated the 
effect of Gpat2 downregulation during normal male germ cell maturation.  We silenced GPAT2 in 
vivo by inoculating mouse testis with lentiviral particles carrying a gene encoding a short-hairpin 
RNA (shRNA) that targeted Gpat2 mRNA.  We found that Gpat2 expression is necessary for the 
normal development of male gonocytes and that its absence triggers apoptosis, thereby 
decreasing the number of dividing germ cells.     
     
Materials and Methods 
Animals, cell lines, culture conditions and ethics statement 
Animal protocols were approved by the Institutional Animal Care and Use Committee (Approval 
Number T10-02-2013) of the School of Medical Sciences, National University of La Plata (UNLP).  
Male BALB/c mice were housed on a 12-h light/12-h dark cycle with free access to water and 
standard chow (Cargill). Before testis dissections, mice were euthanized in a CO2 chamber.  
Cells were purchased from ATCC and grown at 37 °C in a 5% CO2 atmosphere with 98% relative 
humidity. HEK293 and HEK293T human-derived cell lines were maintained in Dulbecco’s modified 
Eagle’s medium (DMEM) (Gibco), supplemented with 10% FBS and antibiotics (50 units/ml 
penicillin and 50 μg/ml streptomycin). 
Gpat2 shRNA selection 
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GIPZ vectors carrying a gene encoding a shRNA targeting Gpat2 transcript (shRNA-Gpat2) or a 
sequence that does not silence any mouse gene (scrambled sequence, Control vector) were 
purchased from Thermo Scientific (Thermo Scientific Open Biosystems Expression Arrest GIPZ 
Lentiviral shRNAmir).  Five different shRNA-Gpat2 vectors were acquired in order to select the 
most effective one.  To test the efficiency of the vectors on Gpat2 silencing, HEK293 human cell 
line was co-transfected with 1 μg of mouse Gpat2 expression vector (pcDNA3.1-Gpat2, as 
previously reported [4]) and 5 μg of one of the different shRNA-Gpat2 vectors or the Control 
vector.  Cell transfection was carried out with Lipofectamine 2000 (Invitrogen), using a 3:1 (v/w) 
Lipofectamine: DNA ratio, in a six-well plate.  Thirty-six hours after transfection, cells were lysed 
and RNA was isolated with TRIzol Reagent (Invitrogen) according to the manufacturer’s 
instructions.  Gpat2 relative expression was evaluated by qPCR, using human TATA-box binding 
protein (TBP) as housekeeping gene.  Primer sequences, shRNA sequences and selection results, 
vector information, and maps can be found in Supplementary Information (Tables S1 and S2, 
Figures S1 and S4). 
Cell fractioning and immunoblotting 
To test Gpat2 silencing at the protein level, HEK293 cells were co-transfected with the Gpat2 
expression plasmid and the shRNA-Gpat2 vector or the Control vector as described above.  Cells 
were then rinsed with ice cold PBS and scraped from the plate with ice cold buffer H (10 mM 
HEPES-KOH, pH 7.4, 0.25 M sucrose, 1 mM EDTA and 1 mM dithiothreitol) with 0.002% v/v 
protease inhibitor cocktail (general use, Sigma) 1:6 (w/v).  Total cellular homogenate was obtained 
by 10 up-and-down strokes in a motorized Teflon-glass vessel.  Samples of 100 μg were separated 
by 8 or 12% SDS PAGE, transferred to a polyvinylidene difluoride membrane (Bio-Rad 
Laboratories), and probed with a 1:500 dilution of anti-GPAT2 antibody [4] or with 1:5000 of anti-
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) antibody (Santa Cruz Biotechnology), as the 
loading control.  Membranes were then washed extensively and probed with 1:5000 dilution of 
horseradish peroxidase-conjugated goat anti-rabbit IgG antibody (Thermo-Pierce).  For 
chemiluminescent detection, membranes were incubated with Super Signal detection kit (Thermo-
Pierce) (Supplementary Information, Figure S1, B). 
Lentiviral Production 
After selecting the most effective silencing vector, lentiviral particles carrying that vector or the 
Control one, were produced in HEK293T cells.  Cells were seeded at 50% confluence in 100 mm 
plates and the calcium phosphate method was used to co-transfect the shRNA-Gpat2 or the 
Control vector (20 μg) with both the VSV-G envelope-expressing plasmid pMD2.G (Addgene, 10 
μg) and the packaging plasmid psPAX2 (Addgene, 20 μg).  Six hours later, the medium was 
replaced with fresh DMEM 5 % FBS and, 24 hours later, the medium was collected and stored at 4 
°C.  This last step was repeated for each plate the next two days.  For lentiviral concentration, 
pooled media was ultracentrifuged for 2.5 hours at 21000 rpm in a SW32 Ti rotor (Beckman 
Coulter); the pellet was resuspended in 200 μl of cold PBS and stored at 4 °C ON.  The next day, 
lentiviral particles were resuspended by pipetting up and down 30 times and stored at -80 °C in 50 
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μl aliquots for up to a month before testis inoculation.  Lentiviral titration was achieved by 
transducing HEK293T cells with serial dilutions of the lentiviral particles and counting the GFP 
expressing colonies under a fluorescent microscope three days later.  If the multiplicity of infection 
was acceptable (~1x108 Transforming Units/ml), testis inoculation was performed. 
Lentiviral Inoculation 
Eleven-day-old mice were anesthetized with isoflurane in O2 (5% for induction and 1% for 
maintenance), an incision was made in the abdomen, testes were pulled out from the abdominal 
cavity and both testes were injected.  Testes were inoculated with 50 μl of lentiviral particles with 
Polybrene (8 μg/ml, Sigma) and the vital dye trypan blue (0.004 % w/v).  The trypan blue stain 
allowed us to follow lentiviral infiltration across the seminiferous tubules.  After inoculation, the 
incision was sutured with a Vicryl suture 8-0, a single postsurgical dose of Tramadol (10 mg/Kg) 
was administered for pain control, and mice were returned to their cages with a nursing female 
mouse (Supplementary Information, Figure S2 A).  Mice were monitored daily to evaluate their 
growth and health.  They were sacrificed one month later and testes were removed. 
To test the injection method and the surgical procedure before lentiviral inoculation, a group of 4 
animals of 11 dpp was inoculated with PBS/trypan blue (0.004 % w/v).  Mice were monitored daily, 
paying special attention to testis descent.  Ten days after inoculation, two mice were sacrificed 
and testes were removed for histological analysis.  The other two mice were mated with two 
healthy females in order to test their reproductive capacity (Supplementary Information, Figure 
S2, B).  
Haematoxylin-Eosin staining and immunohistochemistry (IHC) analysis 
Immediately after removal, testes were submerged in Bouin’s fixation solution for at least 24 
hours.  Then, they were included in paraffin blocks, cut in 4 μm sections, deparaffinized and 
stained.  For haematoxylin-eosin staining, slides were incubated in haematoxylin (Biopack) for 10 
minutes, then rinsed with tap water, incubated for 5 minutes in eosin (Biopack), and rinsed with 
50 % ethanol.  After dehydration, slides were mounted and observed under a white-light Olympus 
BX52 microscope. 
To evaluate the presence of ORF1p (LINE1 derived protein), IAP Gag (IAP derived protein) and 
GPAT2 we performed an IHC and samples were processed as previously described [4].  Slides were 
counter-stained with haematoxylin to visualize the nuclei and analyzed on an Olympus BX52 
microscope. 
Reproductive performance test 
Nine shRNA-Gpat2 and five Control inoculated mice were each mated with two healthy 30-day-old 
females and kept in separated cages.  Breeding began a month after the lentiviral testis 
inoculation, and the test lasted until each female had had three litters.  Sexual behavior, litter size 
and latency to first litter were evaluated.  
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Germ cell purification 
Germ cells were isolated from the testes of inoculated mice as described [26].  Cells were 
incubated overnight at 34 °C in 4 % CO2 to allow Sertoli cells to adhere to the culture plate surface.  
The germ-cell-enriched supernatant was removed and centrifuged for 10 min at 800 g at room 
temperature.  After centrifugation, RNA was purified from cells with TRIzol reagent (Invitrogen). 
 
Analysis of mRNA transcription by qPCR 
After TRIzol purification, RNA quality was determined by gel electrophoresis and 260/230 and 
260/280 nm absorbance ratios.  One μg of total RNA was used for cDNA synthesis employing the 
High Capacity Reverse Transcription Kit (Applied Biosystems).  A 1:10 cDNA dilution was used for 
qPCR (quantitative real-time PCR) with iTaq Universal SYBR Green Supermix (BioRad).  Primers 
were designed to amplify the following mouse genes: Gpat2, Nanos3, Tmem30c, Tpn1, Casp4, 
Cflar, Tnfrsf1a, Rnf7, Birc3, Pak, L15utr, L1orf, IAPltr, IAPgag, and the mouse housekeeping gene 
Rpl13a or the human housekeeping gene TBP (Supplementary Information, Table S1).  The thermal 
profile was 95 °C for 1 min, followed by 40 cycles of 95 °C for 20 sec, 55 °C for 50 sec and 60 °C for 
30 sec, on a Stratagene Mx3500P apparatus.  RNA expression was quantified in duplicate using the 
ΔΔCT method, and each sample was normalized to the corresponding housekeeping gene using 
qBase software. 
Mouse Apoptosis Array: to test the expression of genes related to the apoptosis cell signaling 
pathway, we employed a qPCR based RT2 Profiler Mouse Apoptosis PCR Array (SA Biosciences) 
designed to cross-examine the expression of groups of genes that are functionally and 
coordinately regulated.  A 0.5 μg sample of RNA was used for cDNA synthesis, which employed 
DEPC-free, nuclease-free MiliQ water and a 1:5 dilution for qPCR.  The thermal profile was 95 °C 
for 1 min, followed by 40 cycles of 95 °C for 20 sec and 60 °C for 90 sec, on a Stratagene Mx3500P 
apparatus.  Raw data were analyzed by SA Bioscience’s PCR Array Data Analysis Web Portal and 
relative levels of gene expression were normalized in all the samples to the expression levels of 
housekeeping genes (Gusb, Hprt, Hsp90ab1, Gapdh and Actb). 
TAG quantity evaluation by thin layer chromatography (TLC)  
 
Total lipids were extracted [27] from shRNA-Gpat2 and Control testes and separated by TLC on 
silica-gel 60 plates (Merck), with a mobile phase composed of hexane - ethyl ether - acetic acid 
(80:20:2; v/v) for neutral lipids. All samples were chromatographed in parallel with pure TAG 
standard.  To calculate TAG content, TLC was carbonized, scanned and analyzed with ImageJ 
software. 
 
Statistics 
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Differences between the control and silenced cells or animals were analyzed by Student’s t test or 
by Analysis of Variance (ANOVA) followed by Tukey´s HSD test. Results were considered significant 
at the 5% level. 
Results 
Lentiviral silencing of Gpat2 arrests spermatogenesis at pachytene stage 
We previously reported that Gpat2 expression in rat and mouse is restricted to male germ cells, 
specifically to primary spermatocytes [4,6], and that expression varies in testis during intra-uterine 
development and postnatal maturation [6].  In mice, Gpat2 mRNA expression peaks at 14-16 
gestational days and at 15 days post-partum (dpp); its spatio-temporal expression correlates with 
piRNA synthesis [6].  To understand the role of GPAT2 in postnatal testis and to test the hypothesis 
that GPAT2 is necessary for normal spermatogenesis, its expression was silenced with lentiviral 
particles (Figure 1).  Based on previous data from PIWI-KO mouse models [22,23,24,25] and 
considering the physical interaction between GPAT2 and MILI, it was hypothesized that in vivo 
Gpat2 silencing would cause similar phenotypic alterations in spermatogenesis progression.  
Before inoculation with lentiviruses, testis integrity and mouse survival were evaluated after 
PBS/trypan blue injection.  Because mouse growth, survival and reproductive capacity were not 
affected after the procedure, we proceeded to inoculate mice with the lentiviral particles. 
To overcome the blood-testis-barrier and to silence Gpat2 only in this tissue, we inoculated 
lentiviral particles carrying a gene encoding a shRNA targeting Gpat2 transcript or a scrambled 
sequence directly into the seminiferous tubules of 11 dpp mice (shRNA-Gpat2 or Control mice, 
respectively).  This age was selected because the testes are sufficiently developed to be easily 
manipulated, and postnatal Gpat2 expression has not peaked yet (15 dpp) (Figure 1, B).  At this 
precise point during the first wave of spermatogenesis (Figure 1,C), the Gpat2 promoter region is 
completely demethylated, thus enabling its transcription [6].   
Histological analysis of testes was carried out a month after lentiviral inoculation (41 dpp).  WT 
testis sections of mice at this age (adult) show a variety of germ cells at different spermatogenic 
stages, including spermatogonia, spermatocytes, spermatids and spermatozoa [11,28,29] (Figure 
1, D).  In contrast, haematoxylin-eosin stained shRNA-Gpat2 testis sections showed several 
seminiferous tubules with deficient spermatogenesis and germ cell maturation, and the absence 
of round spermatids or mature sperm cells (Figure 2).  Despite these defects, the number of 
spermatogonia was not affected.  Because our model is not a KO and lentivirus administration 
might not reach all the seminiferous tubules, we observed tubules with normal appearing 
spermatogenesis as well as tubules with impaired sperm maturation in the same slide of shRNA-
Gpat2 testis sections.  Consistently, the proportion of affected tubules in the shRNA-Gpat2 group 
(average: 49%) was significantly higher than those observed in the Control group (average: 10%)  
(Figure 2, C).  These histological analyses revealed that Gpat2 expression is essential for normal 
spermatogenesis.   
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IHC was carried out to correlate the absence of GPAT2 protein with defective spermatogenesis.  In 
mouse testes inoculated with Control virus, normal histology was observed in all analyzed 
sections, confirming the presence of GPAT2 and its localization in pachytene cells (Figure 3, A).  In 
contrast, the altered tubular histology in shRNA-Gpat2 mouse testis sections correlated with the 
absence of a positive signal for GPAT2 protein (Figures 3, B and C).  With the exception of a single 
sample (Figure 3, C), testes weight, size, and shape did not vary statistically between shRNA-Gpat2 
or Control animals (Figure 2, D).  
To determine when spermatogenesis stops as a consequence of Gpat2 silencing, the expression of 
spermatogenic stage-specific genes was evaluated by qPCR [30].  A significant decrease in Gpat2 
mRNA content in the shRNA-Gpat2 group was confirmed (Figure 4, A) and the expression of 
meiosis-phase or cell-marker genes Nanos3 (spermatogonia), Tmem30 (pachytene spermatocytes) 
and Tnp1 (spermatids) was then measured.  No difference was observed in the expression of 
Nanos3 between groups, whereas Tmem30 and Tnp1 expression was significantly lower in the 
shRNA-Gpat2 group (Figure 4, B).  Consistently, the proportion of decrease in Gpat2 expression in 
shRNA-Gpat2 germ cells (40%) was comparable to the proportion of decrease observed in the 
expression of the pachytene-cell marker gene, Tmem30 (56 %).   
Gpat2 silencing affects reproductive capacity 
To correlate the histological and molecular consequences of Gpat2 knock-down (KD) with 
biological outcomes, the effect of Gpat2 silencing on male reproductive capacity was tested.  
ShRNA-Gpat2 and Control mice were mated with WT females.  Sexual behavior was normal and 
latency until the first litter did not vary between groups.  The Control group had a statistically 
larger first litter compared to the shRNA-Gpat2 group, but the differences disappeared in the next 
two litters (Figure 5, A).  Compared to the histology one month after lentiviral inoculation, 
seminiferous tubules had recovered in both groups.  The average percent of altered tubules was 
26% in the shRNA-Gpat2 group and 1.5% in the Control group (Figure 5, B, D and E).  The 
proportion of affected tubules was still significantly higher in the shRNA-Gpat2 group (18-fold 
higher damage than in the Control group), highlighting the importance of GPAT2 for the post-natal 
development of mouse testes.  Testes weight and size remained similar between groups (Figure 5, 
C and S3). 
The decrease in germ cell number in shRNA-Gpat2 mice seminiferous tubules correlates with 
apoptosis activation, without retrotransposon derepression  
The histological and reproductive consequences of shRNA-Gpat2 mice motivated us to search for 
processes or pathways that might have been affected by the decrease in Gpat2 expression.  TAG 
synthesis was not affected, since the content of TAG did not vary significantly between Control 
and KD testes (Figure S5).   
Because it was previously demonstrated that Gpat2 KD impaired piRNA production in germ cells 
[16] and that piRNAs regulate the expression of retrotransposable elements [31], we evaluated 
the effect of Gpat2 KD on retrotransposon expression.  In shRNA-Gpat2 and Control groups, no 
10 
 
significant differences were observed in the testicular mRNA content of LINE1 and IAP, two of the 
most active retrotransposons in mice [31], (Figure 6, A).    
To determine whether the protein products of LINE1 (ORF1p) and IAP (IAP Gag) have a differential 
expression in germ cells, we performed IHC on testis slides one month after lentiviral inoculation 
and after the reproduction tests.  These showed similar results.   In both Control and shRNA-Gpat2 
testes, the ORF1p was detected in primary spermatocytes, as previously reported [32,33], (Figure 
6, B).  The IHC signal in shRNA-Gpat2 normal tubules was also equal to that of Controls.  The few 
germ cells remaining in the abnormal shRNA-Gpat2 tubules frequently showed a robust positive 
signal for ORF1p.  In contrast to ORF1p IHC, the signal of IAP Gag IHC was low and similar in both 
groups (Figure 6, C).  
Because of the depleted cell number observed in shRNA-Gpat2 mouse tubule sections, we 
assessed the expression profile of genes involved in apoptotic pathways.  Using a 96 well based 
qPCR array, 86 apoptosis-related genes were measured, and their relative expression was 
analyzed.  In shRNA-Gpat2 germ cells, apoptosis-related gene expression was activated (p<0.001), 
with 12 genes significantly upregulated and 2 genes significantly downregulated (cut-off of 
|Log2Fold-Change (FC)|> 1 or < 1, respectively) (Figure 7, A).  The expression of several of these 
genes was confirmed by qPCR (Figure 7, B).  To determine a preference for some apoptotic 
pathway, deregulated genes were classified by gene ontology nomenclature.  This analysis 
revealed no association with any of general apoptotic pathways (extrinsic apoptotic signaling, 
intrinsic apoptotic signaling, extrinsic and intrinsic apoptotic signaling, and regulation of apoptotic 
process) (data not shown).  However, according to Kegg 2016, considering genes with a FC> 1.3, a 
functional enrichment pathway analysis showed a significant association with apoptotic TNF and 
NF-kappa beta signaling pathways (Figure 7, C and Figure S6). 
Discussion  
This study reports for the first time the physiological relevance of GPAT2 expression in testis.  We 
have shown that Gpat2 depletion causes meiotic arrest, a reduction in reproductive fitness, and an 
upregulation of apoptotic pathway genes.  
GPAT2 protein has particular characteristics that markedly distinguish it from other GPAT 
isoforms.  On the one hand, this isoform is ectopically expressed in several types of human cancers 
and has been classified as a CT gene, not only for its tissue distribution, but also for its role in the 
development of a malignant phenotype [7].  On the other hand, GPAT2 is highly expressed in 
testis, where its localization is restricted to pachytene spermatocytes and where both epigenetic 
mechanisms and trans-acting factors regulate its transient expression [6].  Finally, although GPAT2 
is required for piRNA biogenesis (16) and piRNA production is crucial for spermatogenesis 
[22,33,34], neither the role nor the importance of GPAT2 in testicular physiology has been 
evaluated. 
We developed an in vivo model, in which Gpat2 is silenced with lentiviral particles in a tissue-
specific manner.  This experimental design has several advantages.  The phenotype is not as 
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extreme as might occur in a KO model in which prenatal and neonatal testis development would 
be affected.  Further, because GPAT2 is not expressed in somatic testicular cells (i.e. Sertoli or 
Leydig cells) [4], silencing only affects the germ cell lineage.   
Histologically, Gpat2 silencing caused a significant depletion in germ cell number and failure to 
complete spermatogenesis in those tubules where GPAT2 protein was undetectable.  When 
GPAT2 was absent, the architecture of testicular parenchyma was also deeply affected.  Despite 
these findings, testis weight and size did not vary significantly between groups, probably because 
the viral particles did not reach all the tubules equally; however, in animals in which testicular 
architecture was severely damaged, the organ size was drastically reduced (Figure 3, C). 
In combination with the striking histology and to identify the step in which spermatogenesis is 
interrupted in shRNA-Gpat2 testes, qPCR was performed for cellular and spermatogenesis stage-
specific genes. qPCR indicated downregulation of pachytene and spermatid specific genes in 
silenced germ cells, whereas no differences were found in spermatogonia-specific gene expression 
between groups, suggesting that Gpat2 KD prevents germ cells from proceeding through the 
pachytene stage.  The arrest at the pachytene stage correlates with the absence of spermatocytes 
beyond this stage in slides of shRNA-Gpat2 testis.  These observations are consistent with previous 
results showing that GPAT2 mRNA and protein are highly expressed precisely in pachytene 
spermatocytes [6]. 
In accordance with the histological damage observed in shRNA-Gpat2 testes, Control mice had a 
larger first litter than the shRNA-Gpat2 group.  The fact that shRNA-Gpat2 mice had tubules 
depleted in dividing germ cells strongly suggests a decrease in mature spermatozoa number that 
causes an alteration in the reproductive fitness.  However, no differences were observed in the 
next two litters.  This change probably occurred because lentiviral infection transduces a 
percentage of dividing cells but with constant cell replacement and differentiation, non-
transduced germ cells might divide and replace the transduced ones, thus reestablishing the 
number of normally dividing cells and repaired reproductive capacity.  Despite this possibility, 
Gpat2 expression remained significantly lower in the shRNA-Gpat2 group compared to the Control 
group even after the third litter (not shown).  Another possibility is that if lentiviral inoculation did 
not reach all the tubules, the effect of Gpat2 downregulation on reproductive fitness might be 
masked by the great quantity of sperm released in each ejaculation.  
In order to further understand the role of GPAT2 in testicular physiology, and because GPAT2 
protein is involved in piRNA biogenesis through its interaction with MILI (16), and Mili-/- germ cells 
fail to regulate LINE1 or IAP transposons [16,35,36], their expression was evaluated.  No 
differences in IAP or LINE1 were found between Control and shRNA-Gpat2 germ cells. 
 
Retrotransposon deregulation and, particularly, LINE1 overexpression, has been largely associated 
with the ablation of piRNA-related proteins in mouse mutant models [31]. However, ORF1p 
protein, and the corresponding RNA, has also been found in WT testis.  ORF1p expression during 
WT spermatogenesis has been detected in leptotene through mid-pachytene spermatocytes [33], 
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and in elongating spermatids and residual bodies, but not in spermatogonia, mature spermatozoa 
or Sertoli cells [32].  The results obtained after IHC are consistent with these reports.  In both 
control and silenced mice, ORF1p protein was present in spermatocytes and spermatids.  The fact 
that ORF1p in WT spermatocytes is found from leptotene until mid-pachytene stages agrees with 
the fact that, in shRNA-Gpat2 animals, affected tubules show germ cells with a strong positive 
signal. Those positive shRNA-Gpat2 spermatocytes could be leptotene-zigotene or even early-
pachytene arrested spermatocytes that normally express ORF1p.  
 
The role of transposon transient expression in meiosis is controversial. Transposon derepression 
would be dangerous to germ cell genomes, but strictly regulated short-term L1 expression might 
be a requisite or a consequence of the chromatin restructuration during meiosis. In fact, 
retrotransposon DNA sequences are linked to synaptonemal complex formation [33]. 
 
It appears that GPAT2 is necessary to reach or to complete the pachytene stage in which GPAT2 
would interact with MILI to synthesize piRNAs by the primary pathway.  While pre pachytene 
piRNAs are necessary for retrotransposon silencing, the precise function of postnatal pachytene 
piRNAs is not yet well understood [31].  One of their functions is to eliminate bulk mRNA during 
spermiogenesis [20].  Retrotransposon deregulation was first reported in KO mice with impaired 
piRNA synthesis from early embryonic stages [31].  However, postnatal disruption of piRNA 
production in testis may not modify LINE1 or IAP expression.  For instance, MOV10L1 KO in 
postnatal mouse spermatocytes produces a specific loss of pachytene piRNAs without LINE1 and 
IAP derepression [37].  In fact, MOV10L1 co-precipitates with GPAT2 and MILI [16], suggesting that 
GPAT2 may function in a similar way.  In accordance, pachytene piRNAs are produced by primary 
processing and, particularly, GPAT2 is required for primary piRNA biogenesis [16].  Thus, although 
GPAT2 has been linked to piRNA production through its interaction with MILI and its 
downregulation affects piRNA production, it is possible that it is not directly involved in the control 
of retrotransposon expression or, at least, in the expression of LINE1 and IAP transposons. 
 
The canonical GPAT activity, the acylation of glycerol-3-phosphate, does not appear to be linked to 
the phenotype, since a) the final product of the pathway (TAG) did not change in silenced testes 
compared to controls, and b) GPAT2 silencing by 80% in MDA-MB-231 cells did not affect GPAT 
enzymatic activity in vitro (Table S3).  These data show that GPAT2 plays a role that is distinct from 
the synthesis of cellular glycerolipids.  It is most likely that the striking phenotype is a consequence 
of impaired piRNA biogenesis and/or a critical signaling pathway.  Consistent with the latter 
possibility, bioinformatics analysis showed that GPAT2 is the only mouse GPAT that contains 
intrinsically disordered protein regions [38], typical of scaffolding proteins in diverse signaling 
pathways [39,40] (Figure S6).   
 
Because an increase in apoptosis might be the cause of germ cell depletion in Gpat2 silenced 
seminiferous tubules, we evaluated the expression of 84 apoptosis-related genes in shRNA-Gpat2 
and Control derived germ cells.  Twelve genes were significantly overexpressed in the shRNA-
13 
 
Gpat2 group, and 2 genes were downregulated.  The downregulated genes (Pak and Rnf7) are 
anti-apoptotic genes [41,42].  This statistically significant balance (p<0.001) is consistent with an 
enhancement of apoptotic pathways in Gpat2 KD germ cells and, particularly TNF and NF-kappa 
beta (functioning as an activator of apoptosis [43]) pathways were the most upregulated ones.   
The two major apoptotic pathways are the extrinsic or cell death receptor pathway and the 
intrinsic or mitochondrial pathway, but molecules involved in one pathway can influence the 
other.  Apoptosis occurs primarily via the intrinsic pathway during fetal testis development and via 
the extrinsic pathway in postnatal germ cells [44].  Consistently, the receptors of the extrinsic 
pathway were among the most significantly upregulated genes in Gpat2 KD germ cells (Tnfrsf1a, 
Ltbr, Cd40 and Fas, Figure S7).  In summary, these results combined with the observed histological 
consequences, support the conclusion that downregulating Gpat2 results in the enhancement of 
intracellular apoptosis.  It is not clear if apoptosis activation in Gpat2 KD cells occurs as a 
secondary effect to the meiotic arrest after the activation of the “pachytene checkpoint” [45], or if 
GPAT2 is directly involved regulating apoptosis.  Supporting the latter possibility, it was previously 
demonstrated that GPAT2 silencing makes MDA-MB-231 breast cancer cells more sensitive to 
staurosporine induced apoptosis, whereas GPAT2 overexpression makes cells more resistant to 
apoptosis [7]. 
Conclusion 
In conclusion, this study reflects the importance of GPAT2 for the normal progression of 
spermatogenesis and the postnatal development of the testis.  It also implies that GPAT2 regulates 
the activation of apoptotic pathways and is an essential protein for germ cell survival.  Further 
experiments are needed to specify the exact molecular mechanisms by which GPAT2 influences 
apoptosis-related gene expression and promotes meiosis fulfillment.  
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Figure 1 
 
Figure 1. Experimental outline.  (A) The timeline shows when lentivirus were produced, 
concentrated and injected into mice, and when testes were collected.  (B) Gpat2 relative 
expression during postnatal testis maturation in WT mice [6].  The syringe indicates Gpat2 
A 
C 
D 
B 
expression when lentivirus are injected (11 dpp) and the word “Adult”, indicates the level 
of Gpat2 expression in adult WT mouse testes.  (C) A schematic timeline for the first wave 
of mouse spermatogenesis.  The syringe indicates the stage of most germ cells when 
lentivirus are injected.  (D) After the first wave, all stages of spermatogenesis can be 
observed in the adult mouse testes. Sg: spermatogonia, Sc: spermatocytes, Sd: spermatid. 
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Figure 2. Gpat2 silencing in mouse testis impairs spermatogenesis.  Mouse testis were 
inoculated with (A) Control or (B) shRNA-Gpat2 lentivirus in two independent experiments 
(n=4).  Animals were sacrificed one month after the lentiviral inoculation.  Slides were 
stained with haematoxylin-eosin.  Six sections were analyzed from each animal.  Pictures in 
A and B are representative and correspond to one sample testis from Control group or 
shRNA-Gpat2 group, respectively.  Magnifications are indicated in the lower right corner.  
Scale bars: 50 μm.  (C) Percentage of affected seminiferous tubules ± SD.  Student’s T test, 
* p<0.05.  (D) Testes weight was similar between groups. 
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Figure 3. GPAT2 evaluation by IHC in Gpat2 silenced or Control mouse testis.  IHC was 
performed on slides from mouse testis inoculated with (A) Control or (B and C) shRNA-
Gpat2 lentivirus in two independent experiments (n=4).  Animals were sacrificed one 
month after lentiviral inoculation.  Six sections from each sample were analyzed.  GPAT2 
presence was detected by peroxidase reaction (brown stain) and nuclei were 
counterstained with haematoxylin (violet-blue stain).  A representative testis section from 
one Control group animal (A) and two representative testis sections from two different 
shRNA-Gpat2 animals (B and C) are shown.  Magnifications are indicated in the lower right 
side of each image.  Scale bars: 50 μM. 
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Figure 4. Gpat2 silencing prevents germ cells from proceeding through the pachytene 
stage.  (A) Gpat2 and (B) spermatogenesis-stage or cell-specific gene expression was 
measured by qPCR, using Rpl13a as housekeeping gene.  Under the histogram, a graphic 
B A 
representation of spermatogenesis was included to show the stage at which each gene is 
predominantly expressed.  Mean values ± SD from two independent experiments are 
shown. ** p<0.01; *p<0.05; N/S: no significant.  Student’s t test and ANOVA-Tukey HSD 
test.  
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 Figure 5. Gpat2 silencing affects reproductive capacity.  Nine or 5 mice were injected with 
shRNA-Gpat2 or Control lentiviral particles, respectively. Each male was paired with two 
WT females.  The experiment continued until each female had had three litters.  (A) 
Average number of pups is shown per birth, per litter ± SD. Student’s t test, *p<0.05.  
Mouse testicular sections were obtained after the reproductive capacity test in order to 
assess the degree of damage produced at 4 months after Gpat2 silencing.  (B) Average 
proportion of affected tubules of each group.  (D and E) Representative slides from each 
group.  Magnifications are shown at the lower right side of each image.  Scale bars: 50 μM 
Student’s t test, * p<0.05.  (C) Testes weight was similar between groups. 
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 Figure 6. Gpat2 silencing does not alter retrotransposon expression.  (A) LINE1 and IAP 
mRNA expression was measured by qPCR, using Rpl13a as the housekeeping gene.  Mice 
were inoculated with shRNA-Gpat2 (n=7) or Control (n=5) lentiviral particles. After 30d 
germ cells were purified for RNA extraction.  Mean values ± SD from two independent 
experiments are shown.  No significant differences were detected between groups 
(ANOVA-Tukey HSD test). (B) LINE1-ORF1p was detected by IHC (brown stain) and nuclei 
were counterstained with haematoxylin (violet-blue stain).  Negative control images are 
displayed in the third column.  (C) IAP Gag IHC signal was not different between groups.  
Magnifications are indicated at the top of the columns.  Scale bars: 50 μM. 
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Figure 7. Gpat2 silencing triggers the expression of apoptotic-related genes.  Mice were 
inoculated with shRNA-Gpat2 (n=7) or Control (n=5) lentiviral particles respectively. One 
month later germ cells were purified for RNA extraction.  (A) Apoptosis-related genes were 
measured with RT2 Profiler Apoptosis Array and results are shown as the ratio between 
iRNA-Gpat2/SCR gene expression (FC).  Only genes with a Log2FC (LFC)>1 (12 genes) or 
LFC<-1 (2 genes) are shown.  The number of upregulated genes is significantly higher than 
the downregulated ones (p<0.001, Chi-Square test), indicating a progression towards 
apoptosis in Gpat2 silenced germ cells.  (B) Six of the deregulated genes were confirmed by 
qPCR.  Bars indicate the means ± SD of two independent experiments; * p < 0.05; ** p < 
0.01 (Student’s t test).  (C) Functional analysis, according to gene ontology of upregulated 
genes with an FC≥ 1.3, revealed that TNF and NF-kappa beta apoptosis were the most 
affected pathways.  
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Supplementary Information 
Table S1. Primers used in this study. 
Gene Primer sequence 
Gpat2  
Forward ATCCTACTGCTGCTGCACCT 
Reverse ACAGCAGCTTTGCACTCAGA 
Nanos3 
Forward TTCTGCAGGCAAAAAGCTGAC 
Reverse TTTTGGAACCTGCATAGACACC 
Tmem30c 
Forward TACCTTCCGGAGAAAATGGAG 
Reverse TCACAGTTCGTAGTATCCCAAATA 
Tpn1 
Forward AGCCGCAAGCTAAAGACTCA 
Reverse TTGCGACTTGCATCATCGCC 
L15UTR 
Forward GGCGAAAGGCAAACGTAAGA 
Reverse GGAGTGCTGCGTTCTGATGA 
L1ORF2 
Forward  GGAGGGACATTTCATTCTCATCA 
Reverse GCTGCTCTTGTATTTGGAGCATAGA 
IAP3LTR 
Forward GCACATGCGCAGATTATTTGTT 
Reverse CCACATTCGCCGTTACAAGAT 
IAPGag 
Forward AACCAATGCTAATTTCACCTTGGT 
Reverse GCCAATCAGCAGGCGTTAGT 
Casp4 
Forward AACCCCACATCACTTGTCCT 
Reverse GGTGGGCATCTGGGAATGAA 
Cflar 
Forward GGCAGAGGCAAGATAGCCAA 
Reverse ATCTTGCTCCTTGGCTGGAC 
Tnfrsf1a 
Forward CACCGTGACAATCCCCTGTAA 
Reverse TTTGCAAGCGGAGGAGGTAG 
Rnf7  
Forward TCCAGGTGATGGATGCCTGC 
Reverse AGAGGGCAGCGATTGTTCTG 
Pak7 
Forward AGCGATGGCCGGATAAAGTT 
Reverse GGGGCTCCCCATCAATCATC 
Birc3 
Forward TGCCAAGTGGTTTCCAAGGT 
Reverse CAAAATGCACGATTGCTGCG 
Rpl13A 
Forward ATGACAAGAAAAAGCGGATG 
Reverse CTTTTCTGCCTGTTTCCGTA 
TBP (Homo sapiens) 
Forward TATAATCCCAAGCGGTTTGC 
Reverse GCTGGAAAACCCAACTTCTG 
 
Table S1. Sequences of primers used in this study. All but TBP have been designed against Mus 
musculus. L15UTR, L1ORF2, IAP3LTR and IAPGag primer sequences were obtained from [1].  
 Table S2. shRNA-Gpat2 sequences. 
Clone Identification number Sequence 
1 V2LMM_105431 TGTACATTCAGGAAGAGGC 
2 V3LMM_499833 TGAGGTAGCAGGTGCAGCA 
3 V3LMM_499830 AGGTCTTGAGGTAGCAGGT 
4 V3LMM_499834 TGAACGTCCAGACTGCACT 
5 V3LMM_499835 ACAACACTACATTCACCTA 
 
Table S2. shRNA-Gpat2 sequences. These sequences form part of GIPZ Lentiviral shRNAmir vectors 
(Thermo Scientific), which encode a shRNA that targets different regions of mouse Gpat2 mRNA. 
Each one was cotransfected with Gpat2 expression vector (pcDNA3.1-Gpat2 [2]) into HEK 293 cell 
line in order to select the best silencing vector. Gpat2 expression was evaluated by qPCR and the 
lowest expression was achieved with the clone N° 4 (Figure S1). 
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Figure S1. Gpat2 silencing optimization and shRNA selection. 
 
 
 
 
 
 
 
 
 
 
Figure S1. Gpat2 silencing optimization. (A) shRNA vectors were cotransfected with a Gpat2 
expression vector in HEK 293 cells and 48 hours later Gpat2 relative expression was evaluated by 
qPCR, using human TBP as an internal control. All but the “Gpat2” sample were cotransfected with 
Gpat2 expression vector and the Control vector (with a scrambled sequence) or shRNA vector. The 
mean ± SD from two independent experiments are shown. The most effective silencing vector was 
shRNA 4, reaching a reduction of 80 % in Gpat2 expression in comparison to Gpat2 or Control 
samples. (B) Protein descent was confirmed by Western blot in total cellular homogenate after 
vector cotransfection. 
 
 
Figure S2. Testicular inoculation optimization. 
 
Figure S2. Testicular inoculation optimization in 11 dpp mice.  (A) Four mice were anesthetized with isoflurane 
1 % in oxygen. Firstly, an incision in abdominal cavity was done (1), testes were pulled out from it (2), 
inoculation was done with a 30G needle (3) and finally, the abdominal cavity was closed with 8-0 Vicryl suture. 
Trypan blue was added to PBS in order to follow its penetration across seminiferous tubules (inserted image). 
(B) Ten days after testicular inoculation two mice were sacrificed, testes were removed, fixed in Bouin´s 
solution, 10 μM slides were cut and haematoxylin-eosin stain was performed. A normal histology of an 
immature testis (21 dpp) is observed. The other two animals were mated with two females each to test their 
reproductive fitness. We observed a normal reproductive behavior and capacity, since the litter size and the 
latency for the first litter was statistically equal in comparison to the control mice (not inoculated, not shown). 
Magnifications are indicated in the lower right corner. Scale bars: 50 μM. 
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 Figure S3. Testis size after Gpat2 silencing 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S3. Testis size after Gpat2 silencing.  Representative photos of testis size are displayed.  The 
yellow coloration is a consequence of the Bouin´s fixation solution.  Although shRNA-Gpat2 showed 
more variability in testis size than the Control group testes, no significant differences in their weight 
were observed between groups. 
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 Figure S4. Vector maps. 
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Figure S4. Vector maps of the vectors used for lentiviral production. (A) pGIPZ vectors encoding five 
different shRNA targeting Gpat2 transcript (shRNA vectors) or a scrambled sequence (Control) were 
purchased from Thermo Scientific.  (B) psPAX plasmid is the lentiviral packaging plasmid and (C) pMD2.G is 
the lentiviral envelope plasmid expressing VSV-G protein, which confers broad tropism over a range of 
species and cell type.  Both vectors were purchased from Addgene. 
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Figure S5. TLC for total lipids from shRNA-Gpat2 and Control testes. 
 
 
Figure S5. TLC for total lipids. (A) Ten μl of total lipid extracts were seeded in the bottom of the TLC 
plate and run for 50 min with a mobile phase composed of hexane-ethyl ether-acetic acid (80:20:2; 
v/v) for neutral lipids.  (B) TLC plate was carbonized and analyzed with ImageJ software.  
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shRNA-Gpat2 Control Calibration curve 
Table S3:  Human GPAT2 silencing in MDA-MB-231 cells did not affect total GPAT activity. 
 Control cells GPAT2-KD cells 
Specific Activity (nmol/min/mg prot) 3.05 ± 0.21 3.16 ± 0.43 
Table S3: GPAT activity was assayed as previously described [2].  GPAT2 was stably silenced in MDA-MB-231 cells as 
previously reported [3].  Data are expressed as mean ± SD of an experiment performed in triplicate.  p = 0.58. 
 
 
Figure S6. Intrinsically disordered regions predicted for the 4 isoforms of murine GPAT. 
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Figure S7. (A) Frequency of residues in long disordered regions (%LD) of the 4 known isoforms of mouse 
GPAT, as analyzed using MobiDB (http://mobidb.bio.unipd.it/).  (B) Prediction of the disordered regions of 
murine GPAT2 (yellow blocks). The detailed information of each predictor used can be found at 
http://mobidb.bio.unipd.it/entries/Q14DK4.  
  
Figure S7. Deregulated apoptosis-related genes  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S6. Apoptosis pathways showing deregulated genes in shRNA-Gpat2 compared to Control germ 
cells. The apoptosis pathway scheme was obtained from KEGG 2016 database. Only those genes which 
are most related to apoptosis and which can be found in the pathways are shown. Upregulated genes in 
shRNA-Gpat2 germ cells with a FC>1,5 (Log2> 0,58) are indicated in red, upregulated genes in shRNA-
Gpat2 germ cells with a FC between 1,2-1,5 are indicated in orange and significantly downregulated 
genes are indicated in blue (FC<0,67 (1/1,5)).  
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